Foresee Pharmaceuticals Co Ltd (6576) — Capital Reinvestment Ratio

Latest as of June 2022: 0.00x

Foresee Pharmaceuticals Co Ltd (6576) has a Capital Reinvestment Ratio of 0.00x as of June 2022, meaning it reinvests 0% of its operating cash flow (NT$143.03 Million) in capital expenditures (NT$590.00K). See how leveraged is Foresee Pharmaceuticals Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

NT$143.03 Million

TWD

Capital Expenditures

NT$590.00K

TWD

Data as of

Jun 2022

Most recent filing

Annual Capital Reinvestment Ratio for Foresee Pharmaceuticals Co Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Foresee Pharmaceuticals Co Ltd from None to None. For live market cap and broader valuation context, see Foresee Pharmaceuticals Co Ltd (6576) market capitalisation.

Year	Reinvestment Ratio	Operating CF (TWD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow